A phase 3 study assessed pozdeutinurad compared with placebo in patients with gout who were inadequate responders to prior therapies.
For physicians who have left clinical practice, hassle factor and too stressful are prime motivations for departure, according to a study published online May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results